Treatment options for extended-spectrum beta-lactamase (ESBL) and AmpC-producing bacteria.
about
Antimicrobial Resistance and Molecular Epidemiology of ESBL-Producing Escherichia coli Isolated from Outpatients in Town Hospitals of Shandong Province, ChinaColonization and infection with extended-spectrum beta-lactamase producing Enterobacteriaceae in patients with malignancy.Clinical efficacy of piperacillin/tazobactam in the treatment of complicated skin and soft tissue infections.Structure and Functional Characterisation of a Distinctive β-Lactamase from an Environmental Strain EMB20 of Bacillus cereus.Towards the early detection of β-lactamase-producing Enterobacteriaceae by MALDI-TOF MS analysis.Clinical Outcomes of Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae Infections with Susceptibilities among Levofloxacin, Cefepime, and Carbapenems.
P2860
Treatment options for extended-spectrum beta-lactamase (ESBL) and AmpC-producing bacteria.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Treatment options for extended ...... ) and AmpC-producing bacteria.
@en
type
label
Treatment options for extended ...... ) and AmpC-producing bacteria.
@en
prefLabel
Treatment options for extended ...... ) and AmpC-producing bacteria.
@en
P2093
P2860
P1476
Treatment options for extended ...... ) and AmpC-producing bacteria.
@en
P2093
Emily L Heil
Jacqueline T Bork
Jennifer K Johnson
Ryan G D'Angelo
P2860
P304
P356
10.1517/14656566.2016.1154538
P407
P577
2016-02-18T00:00:00Z